logo

For the Inventor, By the Inventor

Saitama, Japan

Kohji Nakano

This inventor holds 6 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1984-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohji Nakano. Retrieved from https://idiyas.com/inventor/kohji-nakano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 72(Granted Patents)


Company Filing History:

goldMedal6 out of 329 
 
Yamanouchi Pharmaceutical Company Ltd.
 patents

Years Active: 1984-1990

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4904660 - Histidine derivatives as superior renin inhibitors (1990-02-27),
2. 4845211 - Amino-3-substituted-methyl-3-cephem-4-carboxylic acid and lower (1989-07-04),
3. 4699980 - Process for preparing 3-substituted-methyl-3-cephem derivatives (1987-10-13),
4. 4690921 - Cephalosporin compounds and salts thereof (1987-09-01),
5. 4608373 - Cephem compounds (1986-08-26),
6. 4474779 - Cephalosporin compounds (1984-10-02),

Title: The Innovative Contributions of Kohji Nakano

Introduction

Kohji Nakano, an esteemed inventor based in Saitama, Japan, has made significant strides in the field of medicinal chemistry. With a total of six patents to his name, Nakano has developed novel compounds that hold promise in the medical industry, particularly for hypertension treatment.

Latest Patents

Among Nakano's latest innovations are his patents concerning histidine derivatives that serve as superior renin inhibitors. These compounds, represented by a specific formula, are anticipated to be crucial in the development of effective anti-hypertensive agents. His work also includes amino-3-substituted-methyl-3-cephem-4-carboxylic acid, where he has identified various valuable intermediates like 7-amino-3-(2,3-cyclopenteno-1-pyridiniomethyl)-3-cephem-4-carboxylic acid iodide. This innovative approach involves a new process for the preparation of these acids and their derivatives, paving the way for the creation of novel antibacterial agents.

Career Highlights

Kohji Nakano has been associated with Yamanouchi Pharmaceutical Company Ltd., where he has focused on pioneering research and development in pharmaceutical compounds. His commitment to innovation in drug formulation has garnered him recognition in the field of medicinal chemistry.

Collaborations

Throughout his career, Nakano has collaborated with notable colleagues such as Tadao Shibanuma and Noriaki Nagano. These partnerships have fostered a creative environment for developing advanced pharmaceutical solutions and enhancing the overall impact of their collective research efforts.

Conclusion

Kohji Nakano's contributions through his patents demonstrate a dedication to the advancement of medical science. His innovative compounds and collaborative work continue to influence the pharmaceutical industry, underscoring the importance of inventors in today's society. Nakano's ongoing research efforts hold the potential to improve the lives of many individuals facing hypertension and related health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…